1 month Bristol Myers (BMY) Upgraded to Buy: Here’s What You Should KnowZacks

Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.

Bristol · Bristol-Myers Squibb (BMY) · Earnings